These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14126061)

  • 1. EFFECT OF HEXADIMETHRINE BROMIDE ON PLASMA KININ FORMATION, HYDROLYSIS OF P-TOSYL-L-ARGININE METHYL ESTER AND FIBRINOLYSIS.
    EISEN V
    Br J Pharmacol Chemother; 1964 Feb; 22(1):87-103. PubMed ID: 14126061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ON THE ANTI-INFLAMMATORY ACTIVITY OF PROTAMINE SULPHATE AND OF HEXADIMETHRINE BROMIDE, INHIBITORS OF PLASMA KININ FORMATION.
    KELLETT DN
    Br J Pharmacol Chemother; 1965 Jun; 24(3):705-13. PubMed ID: 14340924
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems.
    Cochrane CG; Revak SD; Wuepper KD; Johnston A; Morrison DC; Ulevitch R
    Microvasc Res; 1974 Jul; 8(1):112-21. PubMed ID: 4278273
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON INACTIVATION OF THE ANTIHEPARIN EFFECT OF HEXADIMETHRINE BROMIDE (POLYBRENE)].
    PACCIONE F; MASELLI-CAMPAGNA G; VAILATI G; RUBINO M
    G Ital Chir; 1964 Jul; 20():391-8. PubMed ID: 14214306
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.
    Ogston D; Ogston CM; Ratnoff OD; Forbes CD
    J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional relations between blood clotting, fibrinolysis and kinin-forming systems of blood.
    Buluk K; Czokalo M; Malofiejew M
    Pol Med J; 1971; 10(3):611-8. PubMed ID: 4108022
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass.
    Kikura M; Lee MK; Levy JH
    Anesth Analg; 1996 Aug; 83(2):223-7. PubMed ID: 8694296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
    Austen KF
    Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
    [No Abstract]   [Full Text] [Related]  

  • 12. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.
    EISEN V
    Br Med Bull; 1964 Sep; 20():205-9. PubMed ID: 14209760
    [No Abstract]   [Full Text] [Related]  

  • 13. MACROMOLECULAR PROPERTIES OF HEXADIMETHRINE BROMIDE, AN ANTIHEPARIN AGENT.
    BARLOW GH; COEN LJ; KIMURA ET; KERESZTES-NAGY S
    Proc Soc Exp Biol Med; 1963; 113():884-6. PubMed ID: 14073132
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Moroz LA; Gilmore NJ
    Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current views on the relationship of the kallikrein-kinin system to coagulation and fibrinolysis].
    Poucková P
    Cesk Fysiol; 1977; 26(6):549-54. PubMed ID: 342127
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.